Colin W G Fishwick (Colin Wg Fishwick)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Venues

Journal of medicinal chemistry

IUCrJ

RSC medicinal chemistry

Future medicinal chemistry

University of Leeds

University of Liverpool (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Leeds Oct 1o 2009

United Kingdom

Professor of Medicinal Chemistry :: School of Chemistry

Education History

University of Liverpool Jul 1o 1985

United Kingdom

PHD :: chemistry

Publications

Kyle M Orritt, Lipeng Feng, Juliette F Newell, Jack N Sutton, Scott Grossman, Thomas Germe, Lauren R Abbott, Holly L Jackson, Benjamin K L Bury, Anthony Maxwell, Martin J McPhillie, Colin W G Fishwick
De novo design of type II topoisomerase inhibitors as potential antimicrobial agents targeting a novel binding region. RSC medicinal chemistry 13 (7) (2022)
Lewis D Turner, Chi H Trinh, Ryan A Hubball, Kyle M Orritt, Chi-Chuan Lin, Julie E Burns, Margaret A Knowles, Colin W G Fishwick
From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor. Journal of medicinal chemistry (2021)
Kyle M Orritt, Anthony Maxwell, Colin W G Fishwick, Martin J McPhillie
Exploitation of a novel allosteric binding region in DNA gyrase and its implications for antibacterial drug discovery. Future medicinal chemistry 13 (24) (2021)
Ricky Cain, Ramya Salimraj, Avinash S Punekar, Dom Bellini, Colin W G Fishwick, Lloyd Czaplewski, David J Scott, Gemma Harris, Christopher G Dowson, Adrian J Lloyd, David I Roper
Structure-Guided Enhancement of Selectivity of Chemical Probe Inhibitors Targeting Bacterial Seryl-tRNA Synthetase. Journal of medicinal chemistry 62 (21) (2019)
Kangsa Amporndanai, Rachel M Johnson, Paul M O'Neill, Colin W G Fishwick, Alexander H Jamson, Shaun Rawson, Stephen P Muench, S Samar Hasnain, Svetlana V Antonyuk
X-ray and cryo-EM structures of inhibitor-bound cytochrome bc1 complexes for structure-based drug discovery. IUCrJ 5 (Pt 2) (2018)
Ricky Cain, Jürgen Brem, David Zollman, Michael A McDonough, Rachel M Johnson, James Spencer, Anne Makena, Martine I Abboud, Samuel Cahill, Sook Y Lee, Peter J McHugh, Christopher J Schofield, Colin W G Fishwick
In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors. Journal of medicinal chemistry 61 (3) (2018)

Colin W G Fishwick.css-eqlu8i{font-size:small;padding-left:4px;} (Colin Wg Fishwick)

Publication Activity (10 Years)

Top Topics

Top Venues

Colin W G Fishwick (Colin Wg Fishwick)